Co-Authors
This is a "connection" page, showing publications co-authored by Valentina Grossi and Maurizio Benucci.
Connection Strength
2.587
-
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al. Ann Rheum Dis. 2021 10; 80(10):e166.
Score: 0.240
-
Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab. Immunol Res. 2021 08; 69(4):309-311.
Score: 0.240
-
Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al. Ann Rheum Dis. 2020 Aug 04.
Score: 0.224
-
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Ann Rheum Dis. 2020 Jul 06.
Score: 0.223
-
COVID-19 pneumonia treated with Sarilumab: A clinical series of eight patients. J Med Virol. 2020 11; 92(11):2368-2370.
Score: 0.222
-
Abatacept: from a budget impact model to cost-effectiveness analysis - data from RCT and real life. Clinicoecon Outcomes Res. 2019; 11:405-409.
Score: 0.207
-
Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis. J Inflamm Res. 2018; 11:247-252.
Score: 0.193
-
Ankylosing Spondylitis Treatment after First Anti-TNF Drug Failure. Isr Med Assoc J. 2018 Feb; 20(2):119-122.
Score: 0.188
-
Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases. Biologics. 2018; 12:37-41.
Score: 0.188
-
Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead-based FACS CANTO II cytometers. Cytometry B Clin Cytom. 2018 07; 94(4):674-678.
Score: 0.176
-
Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease. Immunol Res. 2021 12; 69(6):576-583.
Score: 0.060
-
Prevention and control of COVID-19 in the penitentiary of Florence. Clin Chem Lab Med. 2021 05 26; 59(6):e239-e241.
Score: 0.058
-
Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies. J Med Virol. 2021 03; 93(3):1436-1442.
Score: 0.056
-
Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience. J Med Virol. 2020 Sep; 92(9):1671-1675.
Score: 0.055
-
Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Isr Med Assoc J. 2020 04; 22(4):203-210.
Score: 0.055
-
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. Clin Chem Lab Med. 2019 Oct 25; 57(11):1764-1769.
Score: 0.053
-
Are Anti-DFS70 Autoantibodies Protective? Isr Med Assoc J. 2019 Aug; 21(8):509-511.
Score: 0.052
-
Letter to the Editor relating to Clin Chem Lab Med 2018;56(7):1090-1099. Clin Chem Lab Med. 2019 03 26; 57(4):e45-e46.
Score: 0.051
-
Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study. Immunol Res. 2018 02; 66(1):74-78.
Score: 0.047